Overview
In 1922, vitamin E was demonstrated to be an essential nutrient. Vitamin E is a term used to describe 8 different fat soluble tocopherols and tocotrienols, alpha-tocopherol being the most biologically active. Vitamin E acts as an antioxidant, protecting cell membranes from oxidative damage. The antioxidant effects are currently being researched for use in the treatment of diseases causing bone loss, cardiovascular diseases, diabetes mellitus and associated comorbidities, eye diseases, inflammatory diseases (including skin conditions), lipid disorders, neurological diseases, and radiation damage. Though this research is so far inconclusive, vitamin E remains a popular supplement and is generally considered safe by the FDA.
Indication
Vitamin E supplementation is indicated for treatment of vitamin E deficiency which can occur in cystic fibrosis, cholestasis and severe liver disease, abetalipoproteinemia or simply poor diet.
Associated Conditions
- Vitamin Deficiency
Research Report
Vitamin E (α-Tocopherol): A Comprehensive Monograph on its Chemistry, Pharmacology, and Clinical Utility
Section 1: Introduction and Molecular Profile
1.1. Overview and Discovery
Vitamin E is a collective term for a group of eight lipophilic, or fat-soluble, compounds that are essential for human health and possess distinctive antioxidant activities.[1] These eight compounds, known as vitamers, are divided into two classes: four tocopherols (α-, β-, γ-, and δ-tocopherol) and four tocotrienols (α-, β-, γ-, and δ-tocotrienol).[1] All forms are synthesized exclusively by photosynthetic organisms, including plants, algae, and cyanobacteria, and therefore must be obtained from dietary sources.[1]
The history of Vitamin E began in 1922, when researchers Herbert Evans and Katherine Bishop identified a previously unknown dietary component essential for reproduction in rats.[3] Initially designated "factor X," its absence led to fetal resorption.[6] Subsequent research established its identity as a vitamin, and the name "tocopherol" was derived from the Greek words
tokos (childbirth) and pheros (to bring forth).[8] Further investigations isolated and characterized the different forms, identifying α-tocopherol as the most biologically active vitamer in humans and the only form officially recognized to meet human requirements.[2] This specific focus on α-tocopherol has historically dominated research, although recent studies have shed light on the unique and potentially significant biological roles of the other seven vitamers.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2025/04/15 | Phase 4 | Not yet recruiting | |||
2024/01/18 | Phase 3 | Completed | |||
2023/06/18 | Phase 3 | Recruiting | Badr University | ||
2023/03/16 | Phase 2 | Recruiting | |||
2022/11/15 | Phase 4 | Not yet recruiting | |||
2022/08/05 | Phase 4 | Completed | Farjad Zafar | ||
2022/06/08 | Not Applicable | UNKNOWN | |||
2021/08/02 | Phase 2 | Withdrawn | |||
2021/07/27 | Phase 4 | Completed | |||
2021/03/17 | Phase 2 | Active, not recruiting |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
Everett Laboratories, Inc. | 0642-3010 | ORAL | 20 [iU] in 1 1 | 11/28/2011 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
NEUROGEN-E TABLET | SIN08875P | TABLET, FILM COATED | 100 iu | 8/22/1996 | |
VITALIPID N ADULT INJECTION | SIN05208P | INJECTION | 1 iu/ml | 11/14/1990 | |
VITALIPID N INFANT INJECTION | SIN05207P | INJECTION | 0.7 iu/ml | 11/14/1990 | |
CERNEVIT FOR INJECTION | SIN11975P | INJECTION, POWDER, FOR SOLUTION | 11.2 iu/vial | 6/5/2002 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
No NMPA approvals found for this drug. |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
Sheep Placenta 3000mg | 116916 | Aulong Development Pty Ltd | Medicine | A | 3/1/2005 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
---|---|---|---|---|---|
REAL VITAMIN SUPPLEMENT CAP | laer products inc. | 02031272 | Capsule - Oral | 10 UNIT / CAP | 12/31/1994 |
CELL-WISE | melaleuca of canada inc. | 02236914 | Tablet - Oral | 200 UNIT / TAB | 1/12/1998 |
FORMULA CW-CAPLET | body wise international llc | 02138549 | Tablet - Oral | 50 UNIT | 12/31/1995 |
VITAMIN E CAP 50UNIT | 00825433 | Tablet - Oral | 50 UNIT / TAB | N/A | |
Z-FORCE VITAMIN AND MINERAL SUPPLEMENT | dymatize enterprises inc. | 02244582 | Capsule - Oral | 50 UNIT | 12/12/2001 |
VITAMIN E CAP 1000UNIT | icn canada ltd. | 00471208 | Capsule - Oral | 1000 UNIT / CAP | 12/31/1979 |
ORIGINAL BIOSCAL FORTE MULTI-VITAMIN SUPPLEMENT CAPSULES | carram inc. | 02230146 | Capsule - Oral | 11 UNIT / CAP | 4/7/1997 |
VITAMINS A-C-E PLUS LIPASE TAB | trophic canada ltd. | 00374075 | Tablet - Oral | 100 UNIT | 12/31/1967 |
MULTIVITAMIN-MULTIMINERAL FORTE TAB | hall laboratories, ltd. | 01985337 | Tablet - Oral | 30 UNIT | 12/31/1995 |
MULTI VITAMINES - LIQ | land art inc. | 02148242 | Liquid - Oral | 8 UNIT / 5 ML | 12/31/1995 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
---|---|---|---|---|---|
No CIMA AEMPS (Spain) approvals found for this drug. |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Philippines FDA approvals found for this drug. |
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Saudi SFDA approvals found for this drug. |
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Malaysia NPRA approvals found for this drug. |
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
---|---|---|---|---|---|
No UK EMC drug information found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.